ArticleJBMR plus2025
Serum-derived exosomes of young rats protect bone of ovariectomized rats after fatigue loading in vivo.
Article in JBMR plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In patients with postmenopausal osteoporosis, the accumulation of bone microdamage further increases fracture risk. Exosomes derived from the circulatory system of young individuals can reverse age-related defects during bone repair. Therefore, the present study aimed to elucidate the mechanisms underlying the protective effects of exosomes against structural degradation under fatigue-induced damage. To this end, a rat tibial fatigue injury model was established to investigate the protective effects of serum-derived exosomes (SDEs) isolated from young rats on bone after fatigue damage. SDEs were administered via intramedullary injection for 3 wk. The results demonstrated that treatment with SDEs significantly alleviated bone microdamage in ovariectomized rats. Specifically, it decreased cortical bone microcrack density and increased the mineral apposition rate significantly. In the distal trabecular bone region, treatment with SDEs increased bone volumetric bone mineral density (vBMD) and decreased trabecular spacing (Tb.Sp) significantly, with no significant changes in the structure model index. This study revealed that SDEs can rapidly repair fatigue-damaged bone microstructure, improving microstructural parameters in non-weight-bearing (distal tibial) cancellous bone (increased vBMD and decreased Tb.Sp). These findings provide a potential novel strategy for early intervention of microdamage in postmenopausal osteoporosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.